SpyGlass Pharma, Inc. (SGP) stock

SGPNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30

$32.88−0.44 (-1.32%)

Close on Nov 13, 2026Market cap $1.10BP/E –Yield –

SpyGlass Pharma gross margin

Gross margin is gross profit as a percentage of revenue.

SpyGlass Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?